Saturday, February 7, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

Blood pressure drugs more than double bone-fracture risk in nursing home patients

May 15, 2024
in Medicine
Reading Time: 3 mins read
0
Blood pressure drugs more than double bone-fracture risk in nursing home patients
92
SHARES
835
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Records from nearly 30,000 nursing home residents indicate that blood pressure medications more than double the risk of life-threatening bone fractures, according to Rutgers Health research.

Records from nearly 30,000 nursing home residents indicate that blood pressure medications more than double the risk of life-threatening bone fractures, according to Rutgers Health research.

The authors of the study, which appears in JAMA Internal Medicine, said the increased risk stems from the medications’ tendency to impair balance, particularly when patients first stand up and temporarily experience low blood pressure that deprives the brain of oxygen. Interactions with other drugs and low baseline balance in many nursing home patients compound the problem.

“Bone fractures often start nursing home patients on a downward spiral,”  said Chintan Dave, academic director of the Rutgers Center for Health Outcomes, Policy and Economics and lead author of the study. “Roughly 40 percent of those who fracture a hip die within the next year, so it’s truly alarming to find that a class of medications used by 70 percent of all nursing home residents more than doubles the bone-fracture risk.”

While many patients have high enough blood pressure that the benefits of treatment outweigh these dangers, “Such patients require careful observation, particularly when treatment begins, and that’s not happening,” Dave said. “Caregivers think of blood pressure medication as very low risk, and that’s not true in this patient population.”

Dave’s team analyzed Veterans Health Administration data from 29,648 elderly patients in long-term care facilities from 2006 to 2019. Researchers compared the 30-day risk of fractures to the hip, pelvis, humerus (upper arm) radius or ulna (forearm) for patients who began using blood pressure medications with similar patients who didn’t. To maximize the chance that medication use — and not some other factor — drove the different outcomes, they adjusted for more than 50 baseline covariates, such as patient demographics and clinical history.

The 30-day fracture risk for residents who began blood pressure medication was 5.4 per 100 people per year and 2.2 per 100 people per year for patients who took no blood pressure medication.

Further analysis showed drug usage predicted particularly elevated fracture risk in certain subgroups. Patients with dementia, systolic blood pressure above 139 (the first number in the blood pressure reading), diastolic blood pressure above 79 (the second number) or no recent use of blood pressure medication all experienced at least triple the fracture risk of unmedicated patients.

About 2.5 million Americans live in nursing homes or assisted living facilities. Up to 50 percent suffer falls in any given year, and up to 25 percent of those falls result in serious injury.

The Rutgers Health study indicates that blood pressure medication causes many of those falls and that a combination of less medication and better support could significantly reduce the problem.

“Caregivers can’t strike this right balance of risk and reward if they don’t have accurate data about the risks,” Dave said. “I hope this study gives them information that helps them serve their patients better.”



Journal

JAMA Internal Medicine

DOI

10.1001/jamainternmed.2024.0507

Method of Research

Data/statistical analysis

Subject of Research

People

Article Title

Antihypertensive Medication and Fracture Risk in Older Veterans Health Administration Nursing Home Residents

Article Publication Date

22-Apr-2024

COI Statement

Dr Steinman reported receiving grants from the National Institutes of Health during the conduct of the study, honoraria from the American Geriatrics Society, and royalties from UpToDate outside the submitted work. Dr Lee reported receiving grants from the National Institute on Aging (NIA) and from the US Department of Veterans Affairs Health Systems Research and Development Investigator-Initiated Research program during the conduct of the study and outside the submitted work. No other disclosures were reported.

Share37Tweet23
Previous Post

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

Next Post

Acta Pharmaceutica Sinica B Volume 14, Issue 5 Publishes

Related Posts

blank
Medicine

LRRK2R1627P Mutation Boosts Gut Inflammation, α-Synuclein

February 7, 2026
blank
Medicine

3D Gut-Brain-Vascular Model Reveals Disease Links

February 7, 2026
blank
Medicine

Low-Inflammation in Elderly UTIs: Risks and Resistance

February 7, 2026
blank
Medicine

Menopause Care: Insights from Workforce Review and Consultation

February 7, 2026
blank
Medicine

Urinary Clusterin: Tracking Kidney Disease and Treatment Response

February 7, 2026
blank
Medicine

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

February 7, 2026
Next Post
fig 1

Acta Pharmaceutica Sinica B Volume 14, Issue 5 Publishes

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27610 shares
    Share 11040 Tweet 6900
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1017 shares
    Share 407 Tweet 254
  • Bee body mass, pathogens and local climate influence heat tolerance

    662 shares
    Share 265 Tweet 166
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    529 shares
    Share 212 Tweet 132
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    515 shares
    Share 206 Tweet 129
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • LRRK2R1627P Mutation Boosts Gut Inflammation, α-Synuclein
  • 3D Gut-Brain-Vascular Model Reveals Disease Links
  • Low-Inflammation in Elderly UTIs: Risks and Resistance
  • Menopause Care: Insights from Workforce Review and Consultation

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.

Join 5,190 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine